An unnamed 14-year-old boy presented to the hospital three times complaining of fevers and headache. Doctors ran the usual battery of tests for infection, tried to grow cultures from his blood and, when brain swelling forced doctors to put the boy in an induced coma, they completed a brain biopsy. Everything came up inconclusive. Luckily, his family was able to enroll him in a clinical trial where they would use a new, rapid genetic sequencing technique which would analyze all DNA in a sample, not just DNA belonging to the patient. In this way the doctors’ found DNA belonging to foreign host, Leptospirosis in his spinal fluid. A leptospirosis infection is easily treated with penicillin and the boy returned home after a month of therapy. The conclusion: we have the technology, but will hospitals invest in it? The sequencer used cost S100,000 and each test costs $2000. Fortunately, doctors in the ABC article seem to hope that long term the cost-analysis will favor adapting this technology to prevent waste on tests that are outdated and outmoded. Oh and saving people’s lives, that too. Stay tuned.
Read the NBC article based on the New England Journal of Medicine case file.
Sign-Up For The Latest From TGNR
Sunday Brunch5 months ago
The New Quartz App: Uzabase’s Bet on the Future of News on Social Media
Culture3 months ago
Haircuts on US Dollar Bills: Ranked
History4 months ago
How did Hitler Fool Stalin so Badly with the Invasion of the USSR? | WW2 Brain Bucket Reader Q&A
Inspiration3 months ago
Bethel Church Asylum Service Ends with Tamrazyan Residency Granted
Neuronomics5 months ago
“Brain on Fire” By Susannah Cahalan Review | Neuronomics